Penn Medicine Abramson Cancer Center


 

2020 ASCO GI Cancer Update: Are CPIs Superior to 2nd Line Chemo in SSC of Esophagus? Is CROSS Regimen Beneficial in Neoadjuvant HER2+ Esophageal Adenocarcinoma? Are CPIs More Beneficial Than Paclitaxel in Gastric Adenocarcinoma?

453 views
July 14, 2020
Comments 0
Login to view comments. Click here to Login